Skip to main content
Clinical Trials/ACTRN12622000843752
ACTRN12622000843752
Not yet recruiting
未知

Feasible, safety and utility of Endoscopic ultrasound-guided PPG measurement (EUS-PPGM) in patients undergoing liver resection and major intra-abdominal surgeries.

Waikato District Health Board - Waikato Hospital0 sites40 target enrollmentJune 15, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Waikato District Health Board - Waikato Hospital
Enrollment
40
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 15, 2022
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Waikato District Health Board - Waikato Hospital

Eligibility Criteria

Inclusion Criteria

  • · Patients with cancer in the liver (with or without cirrhosis) who are recommended for liver resection or liver transplant
  • · Patients with cirrhosis who are recommended to undergo abdominal surgery

Exclusion Criteria

  • Exclusion criteria
  • · International Normalised Ratio (INR) \> 1\.6 (as part of the standard of care)
  • · Significant ascites
  • · Child\-Pugh C severity of cirrhosis
  • · Presence of large gastric varices or periportal collateral vessels that prevent EUS approach to the hepatic and/or portal vasculature

Outcomes

Primary Outcomes

Not specified

Similar Trials